Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • COHR vs GSK✓SelectedUSD · GSKCOHR vs GSK performance historyLatest closeAs of-12.90%11/20
Stock and ETF performance explorer

COHR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+39,840.3%
GSK return
+1,644.3%
Excess return
+38,196.0%
Maximum drawdown
-80.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-12.9%-0.1%-12.8%-12.9%
7D-14.2%-5.3%-8.8%-13.2%
30D-21.2%-3.7%-17.5%-20.7%
3M-35.4%-7.3%-28.2%-34.8%
6M-47.8%-4.2%-43.5%-48.0%
YTD+1.4%+0.9%+0.6%-0.5%
1Y+38.1%+7.3%+30.8%+33.3%
3Y+414.3%+52.7%+361.6%+340.7%
5Y+192.2%+40.1%+152.1%+153.2%
10Y+509.8%+98.7%+411.1%+384.2%
All+39,840.3%+1,644.3%+38,196.0%+20,617.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling